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Abstract
Background: Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) are the main malaria
prevention interventions in Ethiopia. There is conflicting evidence that the combined application of both
interventions is better than either LLINs or IRS used alone. This trial aims to investigate whether the combination of
LLINs (PermaNet 2.0, Vestergaard Frandsen, Lausanne, Switzerland) with IRS using propoxur will enhance the protective
benefits and cost-effectiveness of the interventions against malaria and its effect on mosquito behavior, as compared
to each intervention alone.
Methods/Design: This 2 x 2 factorial cluster randomized controlled trial is being carried out in the Adami Tullu district
in south-central Ethiopia for about 116 weeks from September 2014 to December 2016. The trial is based on four arms:
LLINs + IRS, LLINs alone, IRS alone and control. Villages (or clusters) will be the unit of randomization. The sample size
includes 44 clusters per arm, with each cluster comprised of approximately 35 households (about 175 people). Prior to
intervention, all households in the LLINs + IRS and LLINs alone arms will be provided with LLINs free of charge.
Households in the LLINs + IRS and IRS alone arms will be sprayed with carbamate propoxur once a year just
before the main malaria transmission season throughout the investigation. The primary outcome of this trial will
be a malaria incidence based on the results of the rapid diagnostic tests in patients with a fever or history of
fever attending health posts by passive case detection. Community-based surveys will be conducted each year to
assess anemia among children 5–59 months old. In addition, community-based malaria prevalence surveys will
be conducted each year on a representative sample of households during the main transmission season. The
cost-effectiveness of the interventions and entomological studies will be simultaneously conducted. Analysis will
be based on an intention-to-treat principle.
Discussion: This trial aims to provide evidence on the combined use of LLINs and IRS for malaria prevention by
answering the following research questions: Can the combined use of LLINs and IRS significantly reduce the
incidence of malaria compared with the use of either LLINs or IRS alone? And is the reduced incidence justifiable
compared to the added costs? Will the combined use of LLINs and IRS reduce vector density, infection, longevity
and the entomological inoculation rate? These data are crucial in order to maximize the impact of vector control
interventions on the morbidity and mortality of malaria.
Trial registration: PACTR201411000882128 (8 September 2014).
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Background
Despite remarkable achievements in the fight against
malaria over the last decade, there is still an unaccept-
ably high level of malaria burden worldwide. In 2013,
there were an estimated 198 million cases and 584,000
deaths, of which 80 % of the cases and 90 % of the
deaths occurred in sub-Saharan Africa (SSA) [1]. The
World Health Organization (WHO) recommends the
universal coverage of the population at risk with long-
lasting insecticidal nets (LLINs) [2] and targeted indoor
residual spraying (IRS) with insecticide [3] for the con-
trol and ultimate elimination of malaria. In addition, IRS
has been recommended to be scaled-up for malaria con-
trol across the different malaria endemicities including
high transmission settings in SSA [4]. This has brought
a significant shift from past practices in which IRS was
limited for the prevention and control of malaria epi-
demics, particularly in unstable and seasonal malaria set-
tings [5, 6].
Both LLINs and IRS have been shown to be effective
in reducing malaria transmission when applied inde-
pendently [7–9]. As a result, both interventions are
widely applied for malaria prevention in many coun-
tries [10]. Of the 45 countries in Africa with ongoing
malaria transmission, 38 adopted both the WHO’s
policy of universal coverage with LLINs to popula-
tions at risk and IRS with insecticide [1]. In an effort
to accelerate the control and ultimate elimination of
malaria, IRS in combination with LLINs has also
been deployed in the same geographical areas in 31
African countries [1]. The available evidence suggests
that the joint intervention of the LLINs and
IRS should be scaled up and that the combined
effect of these interventions should be further evalu-
ated [11–13].
Despite an increasing interest in the simultaneous use
of both interventions, there are currently no clear guide-
lines on how these interventions should be combined
[14]. At the same time, there is also a paucity of evi-
dence as to whether their combined use is more effective
in reducing the incidence of malaria than using either
intervention alone [8, 15–17]. It is poorly understood
how the interventions interact to improve malaria con-
trol. A few non-randomized observational studies and
mathematical modelling exercises suggest a modest ef-
fectiveness, or conflicting results, when combining inter-
ventions for malaria reduction compared to either
intervention alone [11, 12, 15, 17, 18].
Evidence on the effect of the combined use of LLINs
and IRS from community-based field trials is conflicting.
Consequently, it is difficult to draw any conclusions on
whether the combination of IRS and LLINs is beneficial
against malaria compared to one of the interventions
alone. A recent review indicated that only one of the
four published randomized controlled trials showed add-
itional protection against fighting malaria when the use
of LLINs was combined with IRS, compared to either
method alone [14]. A multi-intervention trial in Benin
showed no significant reduction in clinical malaria in
children under 5 years of age from houses sprayed with
bendiocarb in combination with LLINs, compared to
children in houses with LLINs alone [19]. Similarly, in
The Gambia a combination of IRS using dichloro-
diphenyl-trichloroethane (DDT) and universal coverage
of LLINs showed no added protection against malaria
among children of 6 months to 14 years compared to
the universal coverage of LLINs alone [20]. By contrast,
a recent cluster randomized controlled trial in Tanzania,
where the usage of LLINs was less than 50 %, reported
some evidence of added protection against malaria infec-
tion in children 6 months to 14 years from the combin-
ing of insecticide-treated nets (ITNs) and IRS with
bendiocarb compared to ITNs alone [13]. Lines and
Kleinschmidt [21] recently discussed the design issues in
conducting studies involving the combination of malaria
vector control interventions and recommended further
evidence from well-designed trials.
Good evidence on the effectiveness, costs and cost-
effectiveness of malaria interventions will provide import-
ant information for decision-making in policy formulation,
the revision of existing policy and/or the selection of opti-
mal packages of interventions. Since the cost of both
LLINs and IRS is greater than the cost of either interven-
tion alone [22], it is important to estimate and evaluate
whether the potential extra protection gained by combin-
ing both interventions represents good value compared
with the added costs. This is particularly important in
countries in SSA, where a scarcity of resources is the main
impediment to malaria control. A recent review of the evi-
dence of the costs and consequences of large-scale vector
control for malaria concluded that both LLINs and IRS
are highly cost-effective vector control strategies even
though the former method has been identified as more
cost-effective than the latter [22].
Malaria is a major public health problem in Ethiopia
with approximately 65 % of its 90 million population liv-
ing in areas at risk of malaria infection [23]. Mainly due
to altitudinal and climatic features in most parts of the
country, malaria transmission is seasonal and epidemic
[24, 25]. The most important malarial parasites in the
country are Plasmodium falciparum (60 %) and P. vivax
(40 %) [23]. Anopheles arabiensis is considered the main
malaria vector in the country, with An. pharoensis being
a secondary vector.
The National Strategic Plan for malaria prevention and
control in Ethiopia aims at scaling up and sustaining both
LLINs and IRS interventions in malaria endemic areas
[26, 27]. LLINs and IRS are applied either separately or in
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combination, and during the period from 2005–2011,
more than 43 million LLINs were freely distributed to all
households in malarious areas [28]. The Malaria Indicator
Surveys (MIS), conducted in 2007 and 2011, revealed that
65 % and 55 % of surveyed households had at least one
LLIN, respectively, whereas the reported use by children
under 5 years of age, during the night prior to the survey,
within households with at least one net ranged from 60 %
in 2007 to 65 % in 2011 [29, 30].
In Ethiopia, the increased resistance of P. falciparum
to chloroquine and sulfadoxine-pyrimethamine necessi-
tated a change as the first-line antimalarial drug for the
treatment of P. falciparum [31–33]. Consequently,
artemether-lumefantrine (AL, Coartem®, Novartis, Basel,
Switzerland) has been used as a first-line treatment
for uncomplicated P. falciparum infection since 2004
[31]. Several studies have shown that AL remains
highly efficacious against the treatment of uncompli-
cated falciparum malaria and with no report of ad-
verse effects [34–37].
Several studies from Ethiopia have shown a high in-
secticide resistance in malaria mosquitoes, especially
in relation to DDT, malathion, permethrin and delta-
methrin [38–42]. DDT was the primary insecticide of
choice for IRS in the country for a long time until it
was replaced by deltamethrin in 2009. Unfortunately,
resistance to deltamethrin was reported to be very
high [38]. As a result, the National Malaria Control
Program has adopted the use of bendiocarb and pro-
poxur insecticides belonging to the carbamate family
since 2012 [27, 43]. Currently, bendiocarb and propo-
xur are the primary insecticides of choice for IRS in
Ethiopia. Bendiocarb and propoxur are carbamate in-
secticides evaluated and approved by the WHO Pesticide
Evaluation Scheme, both of which have the potential to
control pyrethroid-resistant mosquitoes [44].
This study aims to investigate the effect of combining
LLINs and IRS with propoxur for the incidence of clinical
malaria and the cost-effectiveness of the interventions
against malaria and their effect on mosquito behavior, as
compared to each intervention alone. The overall aim is
to provide information for national and global policy-
makers in their pursuit of improving malaria control by
evaluating resource demands and the combined effect of
both interventions on malaria. This protocol discusses the
rationale for the choice of the interventions and describes
the designs and methodological approaches being used to
determine the effect of each intervention, in addition to
evaluating the effect of the interventions.
A 2 x 2 factorial cluster randomized controlled trial
was chosen to exploit the robustness of this design to
help ascertain the efficacy of the combined interventions
compared to either interventions alone and the stand-
ard routine practice. This protocol was developed
according to the guidelines of the Consolidated Stan-
dards of Reporting Trials (CONSORT) statement ex-
tension for cluster randomized trials [45]. The scientific
value of the inclusion of the control group in this trial
was also extensively debated, as it was believed that this
arm allows a more reliable comparison between the
groups: LLINs + IRS versus LLINs alone or control,
LLINs + IRS versus IRS alone and LLINs alone versus
IRS alone or control. This is the most robust design in
regard to cluster randomized trials to help ascertain the
efficacy of the interventions. This study design is also
believed to make the results more generalizable and ap-
plicable in resource-constrained countries.
Trial objectives
Primary objective
The primary objective of this intervention study is to de-
termine whether the combined use of LLINs and IRS
with propoxur provides additional protection against
malaria (P. falciparum and/or P. vivax) among all age
groups in the study area compared to LLINs or IRS
alone.
Secondary objectives
In the same study population, the secondary objectives
of the trial are to:
1. Estimate the costs of LLINs + IRS, LLINs or IRS
alone compared to the current routine practice,
and to evaluate the incremental costs, effects and
cost-effectiveness of interventions
2. Assess whether LLINs + IRS reduce entomological
parameters, i.e., human biting rates, mosquito
resting density, longevity, sporozoite rates, and the
entomological inoculation rate (EIR) inside houses
compared with LLINs or IRS alone
3. Determine whether LLINs + IRS improves the
hemoglobin (Hb) concentration and reduces anemia
among children under 5 years of age compared with
children in LLINs or IRS alone
Methods/Design
Study setting
This study is being carried out in the Adami Tullu part
of the Adami Tullu-Jiddo-Kombolcha woreda (hereafter
referred to as the Adami Tullu district) in the East
Shewa Zone of the Oromia Regional State in Ethiopia.
The woreda (or district) is a local administrative unit in
the country, followed by kebeles (the lowest government
administrative unit, which is further divided into gares,
or villages). The capital of the district, Zeway (or Batu),
has a latitude and longitude of 7°56′N 38°42′E with an
elevation of 1640 m above sea level. It is located approxi-
mately 160 km south of Addis Ababa along the highway
Deressa et al. Trials  (2016) 17:20 Page 3 of 16
connecting Addis Ababa to Nairobi via Hawassa. The dis-
trict is set in the Great Rift Valley in south-central
Ethiopia, with altitudes ranging from 1500 m to 2300 m.
Administratively, the Adami Tullu district has 48 kebeles,
each with an average population size of approximately
1000 to 5000 people. Figure 1 shows the geographical lo-
cation of the study district and the description of the study
arms in relation to Lake Zeway. The total annual rainfall
is approximately 700 mm, with peaks during the main
rainy season in July (250 mm) and August (220 mm). The
mean minimum and maximum annual temperatures are
14.5 °C and 27.7 °C, respectively.
Based on the 2007 National Census [46], the projected
population size of the district for 2014 was about
173,000 people and the population of Zeway town about
60,000. The main ethnic group is the Oromo, and the
predominant religion is Islam. The majority of the popu-
lation live in rural areas in houses made with mud or ce-
ment walls and thatched or iron roofs. Local residents
primarily depend on farming, livestock rearing, and to a
lesser extent on fishing in Lake Zeway for their subsist-
ence. In 2014, there were one public and one non-
governmental organization hospital, nine public health
centers and 43 health posts in the district. The health
centers are primarily staffed by health officers, nurses,
midwives, pharmacists and laboratory technicians. Each
kebele is intended to have at least one health post staffed
by two health extension workers (HEWs) reporting to
the health center.
Malaria is a leading health problem in the district.
Transmission is seasonal and unstable, with several re-
corded epidemics of varying degrees [47, 48]. The main
malaria transmission season occurs between September
and December each year following the heavy rainfall
between July and August, whereas the smaller peak occurs
during May and June each year following small rains dur-
ing March and April. Lake Zeway, which has many
swampy areas, profoundly contributes to mosquito breed-
ing in the study setting. P. falciparum and P. vivax
co-exist in the area in varied proportions [47, 49]. A
longitudinal community-based study carried out in
1994 revealed a malaria prevalence of 6.8 % (66 % P.
falciparum, 31 % P. vivax and 3 % P. malariae) from
July to December, peaking in September at 12.6 % [50].
Community-based cross-sectional surveys conducted in
October to November 2006 and April 2007 indicated an
overall parasite prevalence of 4.8 %, varying between local-
ities from 1.7 % to 10.4 %, with 88 % P. vivax and 12 % P.
Lake Zeway
Fig. 1 Map of the study area showing location of clusters in the study arms in Adami Tullu district
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falciparum parasite species composition [49]. Artemether-
lumefantrine (AL, Coartem®, Novartis, Basel, Switzerland)
and chloroquine are the first-line antimalarial drugs for
the treatment of uncomplicated falciparum and vivax mal-
aria, respectively. Both LLINs and IRS are the two major
malaria preventive interventions implemented by the Dis-
trict Health Office (DHO).
An. arabiensis is the major malaria vector in the
district and An. pharoensis is considered to have an aux-
iliary role [50]. An entomological study in the past
showed that the former species prevailed from June to
October with peak densities from July to September,
while the latter species peak months were from September
to November [50]. Preliminary insecticide susceptibility
tests showed that An. arabiensis was greatly resistant to
deltamethrin (mortality 14 %), alphacypermethrin (less
than 1 % mortality), lambdacyhalothrin (4 % mortality) and
permethrin (17 % mortality), but susceptible to bendiocarb
and propoxur (mortality 100 %). An. pharoensis was fully
susceptible to all the aforementioned insecticides with a
100 % mortality (MalTrials unpublished pilot data). Adami
Tullu district has been one of the sentinel sites for the
study of malaria epidemiology and entomology in Ethiopia
due to its relatively higher malaria burden [33, 49–52].
Design
This 2 x 2 factorial cluster randomized controlled trial,
called MalTrials, will be carried out for approximately
116 weeks from September 2014 to December 2016. The
village (or cluster) will be the unit of randomization, and
an equal number of villages will be randomized to one
of the four arms: (1) LLINs + IRS, (2) LLINs alone, (3)
IRS alone or (4) control (routine practice). The control
arm will receive the routine standard practice of malaria
prevention of the Ethiopian Malaria Control Program.
Participants
This trial is only being conducted in the rural communi-
ties of the district. The reason for focusing on rural
communities is due to the prioritization of IRS for mal-
aria prevention in these areas. Prior to implementing
intervention and randomizing villages to arms, a census,
mapping, and pilot studies were carried out to estimate
an optimum sample size (Fig. 2).
Adami Tullu District (48 kebeles)
24 kebeles
24 kebeles
Census and mapping in all kebeles
Pilot studies in four 
randomly selected kebeles
13 kebeles adjacent to Lake Zeway and Bulbula 
River determined to be included in the trial
A total of 250 clusters listed 
from the 13 kebeles 
207 clusters identified within 5 km from 
Lake Zeway and Bulbula river
176 clusters within 5 km from Lake 










24 kebeles in Jiddo Kombolcha 
excluded because of distance 
and resource contraints
11 kebeles excluded because of low 
malaria transmission
43 clusters excluded because 









Fig. 2 Flow chart of the study
Deressa et al. Trials  (2016) 17:20 Page 5 of 16
Village inclusion criteria
Villages with a relatively easy access, relatively higher
malaria transmission and located within 5 km from
Lake Zeway will be included in the study. The prelimin-
ary findings indicated that the incidence of malaria was
8 cases per 10,000 person-weeks of observation for
villages within 5 km from Lake Zeway, compared to vil-
lages beyond 5 km from the lake where the incidence
rate was 0.5 cases per 10,000 person-weeks of observa-
tion (MalTrials unpublished pilot data).
Village exclusion criteria
Villages with difficult access, a very low malaria trans-
mission, and located beyond 5 km from Lake Zeway will
be excluded.
Participant inclusion criteria
All consenting residents of households in all clusters will
be recruited for the study.
Participant exclusion criteria
Residents and household heads who are not able to pro-
vide informed consent will be ineligible to take part in
the trial.
Randomization
From a total of 48 rural kebeles in the Adami Tullu dis-
trict, 13 kebeles with a relatively higher malaria transmis-
sion adjacent to Lake Zeway were included in the study
following a census carried out in 24 kebeles and pilot
studies in four kebeles. From the total list of the clusters
in 13 kebeles, 207 were located within 5 km of Lake
Zeway, had a relatively higher malaria transmission, and
were included in the sampling frame, of which 176 were
randomly selected. The randomly selected clusters were
numbered and equally randomized into the four arms
following a computer-generated list using SPSS software,
with a flow chart of the study given in Fig. 2. While the
study is done in Ethiopia, randomization was done in
Bergen in Norway. This was done to prevent selection
bias by concealing the allocation sequence from the field
researchers assigning villages to the four intervention
groups until the moment of assignment. Thus, a re-
searcher not involved in the study randomly allocated a
random number from a random number table that was
used as the seed for the computer-generated list of vil-
lages using SPSS software. The random selection of
households for the entomological sampling was done in
a similar way.
Due to the nature of the interventions, blinding of the
study participants will not be possible, while observer
bias will be reduced wherever possible. Microscopists
shall read blood films blinded to the identity and inter-
vention status of the subjects. By using standard light
traps and exit traps, we shall reduce the mosquito col-
lector bias. Moreover, the entomologists in our research
group will examine the trap catches, which are different
from the trap collectors.
Interventions
Long-lasting insecticidal nets (LLINs)
The LLINs distributed for this trial were PermaNet 2.0
rectangular, 100 denier, light blue, family size (160 cm
width x 180 cm length x 150 cm height) purchased in
June 2014 from the Vestergaard Frandsen Group SA
(Vestergaard Frandsen, Lausanne, Switzerland). The
PermaNet 2.0 net is a factory-treated mosquito net
manufactured with deltamethrin, which is expected to
retain its biological efficacy for a minimum of 20 stand-
ard WHO washes or approximately 3 years under field
conditions [53].
The MalTrials project bought a total of 10,000 Perma-
Net 2.0 LLINs for this trial. The nets were imported and
arrived in the study site on 16 September 2014, and dis-
tributed to study households from 1 to 5 October 2014.
All households in the LLINs + IRS and LLINs alone
arms received new LLINs free of charge at the beginning
of the intervention regardless of the previous ownership,
with householders maintaining their existing nets at the
time of distribution. The number of new LLINs distrib-
uted to each household was based on the household size
recommended by the national malaria guidelines [43],
i.e., one net for a family of 1–2, two nets for a family of
3–5, three nets for a family of 6–7 and four nets for a
family of 8 or more people.
In advance of the LLINs distribution, all village resi-
dents were made aware of the distribution of the nets
through house-to-house visits, village leaders and
community elders. The net distribution was done in
the center of the village based on a pre-determined
registration list of households in each village by the
MalTrials project personnel in collaboration with the
district and village health workers. Households who
did not receive the nets during the distribution sched-
ule were identified and received their nets later. Edu-
cation about, and a demonstration of how to use,
LLINs were given to the recipients by trained field
staff and selected village residents.
With an average of 2.57 nets per household, a total of
3006 households (1599 households in LLINs + IRS and
1407 households in LLINs only) in both arms of the trial
received 7740 LLINs (4157 nets in LLINs + IRS and
3583 nets in LLINs only). The remaining nets were
stored at an ambient temperature under safe storage
conditions to be used for net replacement before the
peak malaria transmission season each year (in August).
Net use and retention at the household level are being
monitored during the weekly household visit.
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Indoor residual spraying (IRS)
Indoor residual spraying with propoxur will be carried
out at three times during the study period in the
LLINs + IRS and IRS alone arms. Spraying will be
done once a year prior to the peak transmission sea-
son at the beginning, the middle and before the end
of the trial, following the national spraying operation
guidelines [43] and WHO operation manual guide-
lines [54]. Propoxur (isopropoxy-phenyl methylcarba-
mate) is highly effective against mosquito vectors for
more than 3 months at a dosage of 2 g/m2 in the
form of a water-dispersible powder (WP) [54], and
will be acquired from the state-owned Adami Tullu
Pesticide Processing Share Company located in the
study district. Propoxur 50 % WP contains 2 g of ac-
tive ingredient and is packaged in 400 g sachets, and
two sachets will be mixed with 8 L of water. Prelim-
inary findings using the WHO susceptibility tube tests
in 2013 showed a 100 % susceptibility of An. arabiensis
and An. pharoensis to propoxur (MalTrials unpublished
pilot data).
We will use the average surface area measurement
per unit structure (110 m2) to be sprayed by a spray
man per day to calculate the correct amount of in-
secticide required for the spraying. All IRS operations
will be carried out in collaboration with the DHO as
per the recommendations of the national guidelines
[43]. A 6-day training on spraying operation will also
be given for locally recruited spray men and supervi-
sors. The spraying teams will be organized by squads
of four spray personnel and a porter, and supervised
by a squad leader. The DHO malaria focal persons
and HEWs will be used to organize, follow-up, and
supervise the daily activity of spray teams, and a
spray equipment and personnel protective clothing
will be obtained from the DHO.
Approximately 12 houses will be sprayed by each
spray operator per day using an 8-liter Hudson X-
pert (HD Hudson Manufacturing Company, Chicago,
IL, USA). Prior to spraying, a community sensitization
will be performed to inform residents in regard to the
safety, purpose and time of spraying. On the day of
the IRS operation, all targeted households will be in-
formed about the schedule, purpose and requirements
of the spraying. The householders will be requested
to prepare and vacate the house before spraying, and
household items such as water, food and cooking
utensils will be removed from the house. Household
members will be allowed to enter the sprayed house
after 30 minutes, and be requested to clean the floor
and bury or burn the dirt. The householders will also
be requested not to wash, paint or re-plaster the
sprayed walls until at least the end of the main trans-
mission season.
Study endpoints
The primary health outcome measure is malaria inci-
dence determined by the detection of P. falciparum or
P. vivax by rapid diagnostic tests (RDTs) in patients with
a fever or having a history of fever within the previous
48 hours upon arrival at health posts by passive case de-
tection (PCD). The sensitivity and specificity of the
RDTs compared with the results of the light microscopy
will be determined. The secondary health outcome
measure is mean Hb concentration in children under
the age of 5 years, which is measured using a portable
photometer (HaemoCue®, Ångelholm, Sweden) at the
end of each transmission season through community-
based house-to-house visits.
The primary outcome measure of the economic evalu-
ation is the total cost of the interventions. The second-
ary outcome measures are the direct and indirect costs
of the intervention from both the provider and societal
perspectives, which includes Disability- adjusted Life
Years (DALYs) and the number of malaria cases averted
by each intervention.
The primary entomological outcome measure is mal-
aria transmission expressed as EIR, estimated as the
mean number of sporozoite infective bites/person/year.
The secondary entomological outcome measures are the
mean number of An. arabiensis/light trap/night, and
mean number of An. arabiensis in spray catches/night
inside houses.
Sample size
Malaria incidence and anemia prevalence
Sample sizes were calculated based on unpublished epi-
demiological data collected in a baseline pilot study in
villages adjacent to Lake Zeway during September to
December 2013. The sample size for the primary end-
point, the incidence of malaria, was calculated using
methods for cluster randomized trials [55] that take
into account the intra-cluster correlation coefficient
(ICC), incidence rate, the expected effect and the power
of the study. Using a baseline malaria incidence rate of
7.85 per 10,000 person-weeks and the coefficient of
variation between clusters within each group, we used
k = 0.27 in the sample size estimation (MalTrials un-
published pilot data). Thirty-five households (approxi-
mately 175 people) per cluster will be followed up for
116 weeks, with 44 clusters achieving a 90 % power to
detect a 25 % reduction in the malaria incidence rate in
the LLINs + IRS arm compared to LLINs alone or the
IRS only arm, using a two-sided 5 % significance level.
We plan to follow approximately 1540 households with
an estimated 7800 people in each arm of the trial
(Fig. 2). Overall, the trial will cover over 31,000 people
from approximately 6100 households. The proposed
sample size is also assumed to suffice in terms of
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having the power to detect a mean reduction between
the study arms of 0.5 mg/ml Hb concentration in chil-
dren under 5 years of age.
Economic evaluation
The sample size calculated for malaria incidence is also
assumed to suffice for the economic evaluation of the
cost of interventions. The sample size for the cost of ill-
ness study (at the patient level) is calculated using a sin-
gle population mean formula. Hence, 260 participants
will be enrolled into the study from the passively de-
tected malaria patients using a consecutive sampling
technique.
Entomological study
We aim to calculate the sample size for the entomo-
logical collections based on the pilot entomological stud-
ies. In a West African study with a 90 % power and 5 %
significance level, it was advised to sample eight houses
from each of 15 clusters of the study arms, but the mos-
quito density was lower [56]. A total of 16 villages (four
per arm) will be randomly selected for entomological
study, in which indoor host-seeking mosquitoes will be
collected by CDC light traps from four houses per arm,
indoor resting mosquitoes from 16 houses per arm using
pyrethrum spray collection and outdoor resting mosqui-
toes from four artificial pit shelters per arm of the study.
Data collection methods
Each household will receive a specific identification (ID)
number tagged onto a colored metal plate placed on the
upper front door of the house. Each inhabitant in the
household will also receive a unique personal, three-digit
ID number (village number/household number/person
number). The latitude and longitude of each household
will be recorded using a hand-held Global Positioning
System (GPS) device. The GPS data will be downloaded
to a computer for the creation of maps of the study vil-
lages and for a spatial analysis of epidemiological, ento-
mological and economic data. Guidelines for the data
collections will be developed during the pilot studies. All
questionnaires and forms will be initially prepared in
English and translated into a local language for data
collection.
Epidemiological data collections
PCD of malaria cases at the health posts will be car-
ried out throughout the trial using RDTs, and thin
and thick blood smears for microscopic examination.
We will recruit 24 data collectors (two data collectors
per kebele) for a weekly household visit, 14 nurses
(one nurse per kebele) for malaria diagnosis and treat-
ment at the health posts and three field supervisors.
Data collectors will be trained on questionnaire specifics,
interviewing techniques and household visits. They will
visit households weekly to help identify residents with
fever, or a history of fever in the last 48 hours, to refer to
the health posts and track information on LLINs’ use by
household members during the night before the survey.
The research team and supervisors will make regular
field visits for quality control of the work done at
health posts. Each field supervisor will be responsible
for 59 clusters, and will meet with data collectors and
health workers at the health posts at least once a week.
During these visits supervisors will check patient regis-
tration books, malaria surveillance forms and the
availability of antimalarial commodities, and collect
completed forms and blood slides and bring them back
to the project’s office. Throughout the study period, all
health posts that participate in the trial will be provided
with multispecies and mixed infection-detecting RDTs,
artemether-lumefantrine (AL) and chloroquine obtained
from the Oromia Regional Health Bureau (ORHB). The
RDT that will be provided is the CareStart® Malaria Pf/Pv
combo test (Access Bio, Inc., Somerset, NJ, USA), which is
individually packaged with an alcohol swab, lancet, capil-
lary tube, buffer and test device.
Through weekly household visits, study participants
with a fever or having a history of fever within the past
48 hours, will be encouraged to present to the health
posts. Residents will be advised to visit the health posts
whenever they develop a fever. They will be asked to
show a household card whenever visiting a health post.
For individuals without a household card, health workers
will use other information that allows them to locate the
household and its number. Individuals who are found to
be positive for P. falciparum by RDT will be given AL
twice a day for 3 days based on body weight according
to national guidelines [31]. AL is a fixed dose combin-
ation of 20 mg artemether plus 120 mg of lumefantrine.
P. vivax positive individuals will be treated with chloro-
quine, 25 mg/kg for 3 days (10 mg base per kg on days 1
and 2, and 5 mg base per kg on day 3). Treatment of
other conditions will be done in accordance with the na-
tional guidelines or a referral to higher level health facil-
ities. Patients with severe illness at the time of visit
(from malaria or other causes) will be referred to the
nearest health facility. Any person from the study vil-
lages treated for malaria at a health center or hospital
will also be included in the study.
Thin films of blood slides will be fixed with methanol
for 30 seconds. Both thin and thick films will be stained
with 3 % Giemsa for 20–30 minutes by experienced la-
boratory technicians in accordance with the standard
malaria laboratory procedures. A thick blood smear will
be declared negative with a minimum of 100 high power
fields by microscopic examination, while the thin film
will be examined to identify the Plasmodium species for
Deressa et al. Trials  (2016) 17:20 Page 8 of 16
positive slides. A second reading for all positive and
negative slides will be performed by an experienced
laboratory technologist and any discordant results will
be resolved by a third reader. All blood slide readers
will be blinded to the different arms of the trial and
to the diagnosis of preceding readers.
At the end of the main malaria transmission season
each year, the Hb concentration will be assessed in
children 6–59 months old for assessing the prevalence
of anemia using a portable photometer (HaemoCue®,
Ångelholm, Sweden) in the field. Through house-to-
house visits, a single finger-prick sample will be taken
from each child, and children’s height and weight will
also be measured. A Hb cut-off point of less than
11.0 g/dl will be used to decide whether a child has
anemia, and will be further classified into mild, mod-
erate and severe anemia.
Community-based malaria prevalence surveys will be
conducted on a representative sample of households
from each arm of the trial during the main transmission
season (September to November) each year among all
age groups. All household members will be eligible to be
included in the study. Allowing for ineligible households,
absence on the day of the survey and refusals at the
household and individual level, approximately 5500 indi-
viduals from 1100 households will be estimated to be in-
cluded in the study. This would provide an average 275
households from each arm of the trial to be included in
the study. The households will be randomly selected
from the total list of households in all arms of the trial.
The heads of the households or their representatives will
be interviewed using a pre-tested structured question-
naire. Voluntary individuals will be tested for malaria
parasites using RDTs. Moreover, blood slides will also be
collected for microscopic examination.
Economic evaluation data collections
Costing will be done based on the cost of the inter-
ventions from a health systems perspective, with cost
data collected by interviewing individual malaria pa-
tients, family members and the DHO personnel. The
main cost outcome measure will be the total costs of
interventions, including all resources used to deliver
the interventions and recurrent costs such as
personnel, supplies and materials, the operation and
maintenance of buildings, utilities and communication
costs, in addition to capital costs such as buildings,
equipment, and vehicles. The costing of the interven-
tion will be done from the provider’s perspective
using a standard malaria costing tool developed by
the WHO [57]. The economic evaluation of health
outcomes will be evaluated by the number of malaria
cases averted and DALYs gained as a result of the in-
terventions using incidence data. The number of
deaths averted due to the interventions will be calcu-
lated based on the case fatality rates of malaria.
Economic evaluation, cost-effectiveness/utility analysis,
presenting cost per malaria case prevented and costs per
DALY averted will all be employed. The DALYs will in-
corporate both morbidity estimates from malaria epi-
sodes and anemia among children. We will develop a
Markov life cycle model to account for the recurrent na-
ture of malaria disease, with a varying amount of risk for
repeated episodes during different seasons of the year.
The cost of illness study will be conducted in the same
district from non-trial villages to account for saved dis-
ease treatment costs. Epidemiological and effectiveness
parameters will be based on the findings of this research
project, while the clinical course of the diseases will be
based on a review of the best available literature. Stand-
ard DALY weights will be utilized. Moreover, this trial
will incorporate an evaluation of the distributional
impact of the interventions using inequality analysis
techniques and a decomposition of the inequality into
various socioeconomic factors using an extended cost-
effectiveness analysis (ECEA). In the ECEA, we will esti-
mate the benefit of the interventions across different
levels of income group in terms of the number of deaths
prevented, the net financial risk protection provided, the
out-of-pocket expenditure averted and the number of
poverty cases prevented.
Entomological data collections
The results of trials from countries where An. gambiae
s.s. is the dominant vector might not be fully applicable
in countries such as Ethiopia, where An. arabiensis is
the main vector. The latter vector is less affected by
mosquito nets, and is more exophilic and less anthro-
pophilic [58]. Estimating the human biting rate (HBR)
of mosquitoes is important for a risk assessment of
malaria transmission. The Centers for Disease Control
and Prevention (CDC) light traps, used in many
studies, are only a proxy measure to estimate HBR.
Human landing catches (HLC) are a more direct way to
estimate HBR, and are often considered the “gold
standard” [59]. Recent research showed that light trap
collections placed close to inhabited mosquito nets may
not be a reliable method of assessing human biting
rates [60].
The CDC light traps and HLC will be compared
before starting the trial. Since HLC cannot be used
for community-wide mosquito collections due to eth-
ical and logistical drawbacks, CDC light trap collec-
tions will be calibrated with HLC locally in order to
estimate an operational conversion factor for calculat-
ing the HBR and EIRs. Mosquito collections will be
carried out during the malaria transmission season
following interventions.
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The CDC light traps, pyrethrum spray sheet catches
and artificial pit shelters will be employed to collect
mosquitoes and assess their biting behavior, indoor
and outdoor resting densities. Houses will be ran-
domly selected from a computer-generated list and
the person will be blinded to the arms and houses.
For CDC light traps and pyrethrum spray catches, the
number of houses will be four and 16 from each arm,
respectively, while four pit shelters in each arm will
be constructed. Mosquitoes will be collected weekly
from August to November each year, and will be
identified to species using a morphological key [61].
Previous studies indicated the presence of An. arabiensis
as the only species of the An. gambiae complex in the
study area [50]; however, for reconfirmation purpose a
species-specific polymerase chain reaction (PCR) will be
applied [62].
From all collections, blood-engorged female mosqui-
toes will be analyzed using Enzyme- linked Immuno-
sorbent Assays (ELISAs) for determining the blood meal
source of vectors in indoor or outdoor situations [63].
All collections of female anophelines, with the exception
of blood-fed mosquitoes, will be subjected to a sporozo-
ite test by employing ELISA [64] and a parity determin-
ation by ovary dissection [65].
Insecticide resistance in An. arabiensis and An.
pharoensis will be monitored annually throughout the
study period using standard WHO tube tests [66].
The insecticides will be the pyrethroids (deltamethrin,
alphacypermethrin, permethrin and lambdacyhalo-
thrin) and the carbamates (bendiocarb and propoxur).
In order to assess any change in resistance, the resist-
ance intensity will be quantified. For the insecticide
susceptibility tests, larvae and pupae of the two spe-
cies will be collected from breeding habitats and
reared to adults. The status of physiological suscepti-
bility/resistance of females will then be determined.
Molecular [67] and biochemical analyses [68] will be
used to identify potential insecticide resistance mech-
anisms. Sporozoite rates will be determined by ELISA
and rechecked by real-time PCR [69]. The decay rate
of propoxur will also be assessed monthly by conducting
cone wall bioassays on eight randomly selected houses
from the two arms (IRS and LLINs + IRS) [70] for a
period of at least 6 months post spraying. An insectary
colony of An. arabiensis (Debre Zeit strain, being main-
tained at the Aklilu Lemma Institute of Pathobiology,
Addis Ababa University since 2001), which is susceptible
to all insecticides including propoxur, will be used for the
bioassay test.
Data management
Data will be collected using standardized paper-based
forms and questionnaires according to standardized
operating procedures. Data will be entered into a com-
puter by trained data entry clerks, we will verify data by
range and consistency checks, and data cleaning will be
done weekly. Any discrepancies will be corrected by
cross-checking against the corresponding original forms
and subsequently amended in the final dataset.
All blood slides will be labelled with the patient’s
unique ID number and date of collection to help ensure
anonymity. To minimize any loss to follow-up, we will
keep following up all residents and maintain their data-
base, even if they move out of the trial area or move
from one cluster to another cluster with a different
intervention. For residents or respondents who are not
present at the time of the visit by project staff, basic in-
formation about dates and reasons for absence will be
sought from other community members such as friends
or neighbors. The epidemiological data, economic
evaluation data and entomological data will all be kept
separately. All databases will be password protected
and only accessed by research team and data entry
clerks for data entry, cleaning and analysis. Further-
more, data will be stored for at least 5 years and be
made publically available.
Each of the principal investigators of the epidemio-
logical, economic evaluation and entomological studies
will maintain records in compliance with Good Clinical
Practice (GCP) for regulatory or institutional require-
ments. Authorized representatives from the funding
agency, ethical committees or regulatory bodies may in-
spect all documents and records of the trial. The re-
search team will explain any deviation from the
originally approved protocol. Moreover, any deviation
from the protocol that will have an impact on the con-
duct of the study will also be immediately reported to
the funding agency and the local Institutional Review
Board (IRB) as appropriate.
Analytical plan
The primary health outcome measure is malaria inci-
dence determined by the detection of P. falciparum or
P. vivax using RDTs. All analyses will be conducted on
an intention-to-treat basis, regardless of whether the
individual household members use LLINs, IRS or not.
Malaria cases diagnosed with an infection within
28 days of the first episode with the same Plasmodium
species will be censored and will not be included in the
analysis. An analysis will be performed as a community
randomized trial with time-person as the denominator.
All analyses will be conducted using Stata version 13
(StataCorp LP, College Station, TX, USA), and primary
and secondary outcomes will be compared between the
different intervention arms and control groups. The
main outcome variable, malaria incidence based on
PCD, is assumed to follow a Poisson distribution based
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on a random and independent occurrence. Hence, a
generalized Poisson log linear model will be fitted to
measure for associations between the outcome variable
and predictors. The main outcome variable will also be
analyzed as a binary variable and will be compared in
the intervention and control clusters using multilevel
mixed-effects logistic regression models, taking into ac-
count the clustering effects. In addition, we will also
analyze the data using the population as the denomin-
ator (e.g., with a generalized estimating equation (GEE),
multilevel analysis or spatial analysis) to help assess the
effect of the intervention.
To control for potential confounding factors, the clus-
tering effect of villages, the effect of repeated measure-
ment in the same individual and individual level
covariates (such as age, gender, LLINs’ use) will be taken
into consideration during the analysis. Other potential
confounding factors will also be adjusted for in the re-
gression analysis, and all estimates will be presented with
95 % confidence intervals. Time will be included as a
fixed effect that will allow any interaction with the inter-
ventions to be quantified.
The WHO age-adjusted cut-off for Hb will be used
to classify anemia in children [71]. For children be-
tween 6–59 months of age, a normal Hb level is de-
fined as Hb of 11.0 g/dl or greater and as mild at
10.0–10.9 g/dl. Moderate anemia is defined as chil-
dren with an Hb level of 8.0–10.9 g/dl while severe
anemia is defined as an Hb level of less than 8.0 g/dl.
At a community level, a prevalence of anemia will be
stated to be severe if over 40 % of the children are
anemic (combining mild, moderate and severe) and
moderate if the prevalence is 20–39.9 %. We will
measure the weight and height of all children under
the age of 5 years, and calculate the anthropometric
indices such as weight for height, height for age, and
weight for age. Both malaria and anemia prevalence
data will be compared in the intervention and control
clusters using multilevel mixed-effects logistic regres-
sion models, taking clustering effects into account.
Cost-effectiveness, expressed as an incremental cost-
effectiveness ratio (ICER), will be calculated for each
outcome and arm using standard DALY weights. The
interventions will be ranked according to cost-
effectiveness, whereas inequality in terms of health
outcomes, will be measured by the Gini coefficient
and the concentration index [72].
The agreement between the two mosquito collection
methods, HLC and light traps, in assessing mosquito
sampling efficiency will be calculated by a parametric
approach based on an analysis of variance and simple
graphical methods. Indoor and outdoor Anopheles dens-
ities will be compared among the study arms using a
one-way analysis of variance (ANOVA) if data are
normally distributed or using a Mann-Whitney U test if
data are non-normally distributed.
Ethical considerations
Ethical approval
The study was approved by the IRB of the College of
Health Sciences at Addis Ababa University, the Ministry
of Science and Technology in Ethiopia (ref: 3.10/446/06)
and the Regional Committee for Medical and Health Re-
search Ethics, Western Norway (ref: 2013/986/REK Vest).
The protocol was registered online on 8 September 2014
at the Pan African Clinical Trials Registry under the regis-
tration number PACTR201411000882128.
Community consultation and sensitization
Prior to the implementation of interventions, a consulta-
tive workshop and several meetings were held to explain
the objectives, kebele selection and randomization, im-
plementation procedures and expected outcomes of the
trial to the communities with representatives from the
ORHB, the East Shewa Zone Health Department and
the Adami Tulu District Administration. Permission
through official letters was obtained from various ad-
ministrative levels. Study communities were sensitized
prior to randomization through meetings and discus-
sions with community leaders, kebeles and village leaders
and community elders.
Information and informed consent
Verbal informed consent to participate in the study was
obtained beforehand from the study participants and
from parents/guardians for children under 18 years of
age using the local Afan Oromo language. Information
sheets were provided to inform about the purpose of the
study, and the participants were informed that involve-
ment in the study was voluntary and that they had the
right to withdraw at any time regardless of reason. At
each data collection, the verbal consent of the study par-
ticipants and verbal assent from the parents/guardians
for children were obtained using the local language. As-
surance was also given that a refusal to participate in
this study would not affect their access to services at the
health posts in the study villages in the community.
Adverse events and malaria treatment
We do not anticipate any physical harm or risks to the
participants. Blood samples for RDTs, microscopic
examination of slides and Hb measurements will be col-
lected using aseptically disposable lancets. A finger-prick
for blood sample collection may result in mild pain and
bruising at the site where blood is obtained, but will not
cause any further harm. The collection of blood samples
from finger-pricks is part of the routine procedures in
the diagnosis of malaria by health workers. Malaria
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treatment will be provided according to the national
guidelines using AL and chloroquine, which are the
first-line antimalarial treatments for P. falciparum and P.
vivax, respectively [43]. All study participants visiting
health posts will be examined and treated for malaria
free of charge, while the mass distribution of LLINs and
IRS spraying will be carried out by the MalTrials project
for free in collaboration with the DHO. Mosquito collec-
tors will be trained to collect mosquitoes as soon the
mosquitoes land and before they bite. To help minimize
risk, data collectors will be provided with an appropriate
prophylactic drug (Malarone) before the collections.
Confidentiality of information
To the best of our ability, all information from the study
households and participants will be held in confidence
and appropriate measures will be taken to ensure the
confidentiality of information both during and after data
collection. Access to information will be limited to data
collectors, including health workers and their supervi-
sors at sites of collection, data entry clerks and to the re-
search team.
Trial oversight
There is no need for a Data Safety and Monitoring Board
(DSMB) for this trial since all interventions, blood sample
collection and treatments are part of routine malaria con-
trol in Ethiopia and will be undertaken in collaboration
with the health workers at the health posts and the DHO.
We do not foresee any adverse effects from the interven-
tions, so we do not intend to apply any stopping rules for
this trial. No participant in the control group will be im-
peded from obtaining mosquito nets from other sources,
and malaria incidence in the control villages will be moni-
tored throughout the study for possible case build-up or
an outbreak of malaria. If the control villages encounter
any malaria outbreaks, an intervention will be taken by
the MalTrials project and the DHO in accordance with
the national guidelines regardless of the trial.
Deltamethrin-treated LLINs and propoxur IRS are
WHO recommended and meet the specifications of the
WHO’s Pesticide Evaluation Scheme, and our interven-
tions will follow the WHO and national recommenda-
tions [44, 73]. The hazard which may be associated with
this trial is that the insecticides used for the IRS could
leak into the environment. Empty sachets, cartons, plas-
tic bags, used gloves, pricking needles and other con-
taminated materials will be handled properly until they
are finally burned. Lastly, all needle safety procedures
will be in line with WHO standard.
Timelines of activities
The trial is being carried out for a period of approxi-
mately 116 weeks from September 2014 to December
2016, with Table 1 showing details of the timetable of
activities.
Discussion
In an effort to accelerate the reduction and ultimate
elimination of malaria, IRS with insecticide and the uni-
versal distribution of LLINs have been implemented in
recent years in many countries in SSA. It is well-
accepted that decisions regarding malaria interventions
should be based on robust evidence of the benefits and
cost-effectiveness of the interventions. Since the rollout
of both interventions requires considerable resources,
there is an urgent need to evaluate additional protective
benefits and the cost-effectiveness of the combination of
the interventions. This study aims to measure whether
IRS in combination with LLINs increases protection
against malaria incidence compared to the use of LLINs
alone, IRS alone or current routine practices. The inter-
vention will consist of four “arms”: LLINs + IRS, LLINs
alone, IRS alone and control (routine practice).
The main outcome of the trial will be the assessment
of the incidence of malaria using PCD at health posts.
Our sample size is relatively large compared to other
trials, e.g., a study in the Gambia used 35 clusters of 110
children in each of two arms to detect a 50 % reduction
in the incidence of malaria [56]. Our preliminary sample
size calculations based on malaria incidence rates in
southern Ethiopia [60] showed that we might need to in-
clude 10 clusters per arm with approximately 50 house-
holds (250 persons) per cluster. However, a Cochrane
review advocates large-sized clusters [8].
Conducting research to evaluate the impact of com-
munity interventions raises a number of practical issues
[21]. Both LLINs and IRS interventions are implemented
by the project, and we anticipate that the coverage of
the interventions will be very high despite issues of net
use and the re-plastering of sprayed walls of the houses.
We understand that the recent relatively low incidence
of malaria in the area will have an impact on the proper
and consistent use of LLINs by the community, which
may challenge an active participation by the community.
We will monitor LLINs ownership and use by household
members on a weekly basis, and we will also assess the
magnitude of the re-plastering rates of houses and teach
the community about its consequences on malaria.
Some of the strengths of our study are that we have
carried out extensive pilot studies before starting the
trial. This enabled us to estimate the variance in malaria
incidence among the villages and thus the sample size.
In the previous published trials, the IRS insecticide was
bendiocarb which has a relatively short residual duration
on the walls, or DDT, against which the insecticide re-
sistance has become widespread [38–42]. The current
trial evaluates the added protection of propoxur, which
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Table 1 Timetable of activities
Activity by year and month J F M A M J J A S O N D
2013
Ethical approval x x x x x x x x x
Development of data collection tools x x x x x x x x
Census and mapping x x
Epidemiological pilot study x x x x
Entomological pilot study x x x x x x
2014
Selection of clusters x x x x
Randomization of study clusters x
Procurement of LLINs x x x x x x
Procurement of insecticide x x x
Household numbering and tagging x x
Baseline data collection x x
LLINs distribution x x
Protocol registration x x
IRS spraying x
LLINs distribution x
PCD and weekly household visit x x x x
Entomological surveys x x x x x
Cost data collection x x x x
2015
Anemia survey x
Malaria prevalence survey x x x
PCD and weekly household visit x x x x x x x x x x x x
Entomology lab assays and field surveys x x x x x x x x x x x x
Cost data collection x x x x x x x x x x x x
IRS spraying and LLINs’ replacement x
Data entry and cleaning x x x x x x x x x x x x
Sensitization of study population x x x
2016
Anemia survey x x
Malaria prevalence survey x x x
PCD and weekly household visit x x x x x x x x x x x x
Entomology lab assays and field surveys x x x x x x x x x x x x
Cost data collection x x x x x x x x x x x x
IRS spraying and LLINs’ replacement x
Data entry, cleaning and analysis x x x x x x x x x x x x
Entomological lab assays and field surveys x x x x x x x x x x x x
Cost-effectiveness analysis x x x x x x x x x x x x
2017
Dissemination of findings to the study community x x
Data analysis and report writing x x x x x x
Scientific writing and publications x x x x x x x x x x x x
Final report to the funding agency x x x
Dissemination of findings to stakeholders x
LLINs long-lasting insecticidal nets, PCD passive case detection
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has a relatively longer duration on walls compared to
DDT. In addition, we also determined that the anophel-
ine vectors in the study area are susceptible to propoxur.
One of the limitations of this trial is that the communi-
ties will not be masked or blinded to the intervention.
This would create a bias towards an increased effect of
the combined intervention compared with other arms of
the trial. This trial will not use a buffer zone between
clusters of the different interventions as it will be carried
out in rural areas with scattered households. As a result,
the proximity of the clusters may influence the re-
sults. However, this applies to only some of the se-
lected villages that are close to each other. As the
positions of all households are recorded, we shall also
try to adjust for possible close proximity of the vil-
lages during analysis.
The community in the “routine practice” with a
weekly follow-up is in a better position than the com-
munity in the “routine practice” without any follow-up.
Therefore, we decided to allow the trial with all four
arms and emphasized that every participant will have
access to weekly visits by the MalTrials project field
personnel, early diagnosis and state of the art treatment
for malaria. Adami Tullu was one of the 19 IRS tar-
geted districts of the President’s Malaria Initiative
(PMI) and the Ministry of Health (MOH) between 2008
and 2013 [74]. However, since 2014 the PMI has shifted
its target areas to other districts in the Oromia Region.
However, we will continuously monitor all groups in-
cluding the control arm of the study if unforeseen mal-
aria epidemics should arise.
This study is proposed at a time of significant need
within the countries of SSA on how to effectively use
IRS and LLINs interventions for malaria control and
elimination. Consequently, the study is well-timed to as-
sess whether the combination of LLINs and IRS could
contribute towards the elimination of malaria. The trial
addresses how to promote the uptake of research find-
ings into public health programs by enhancing the
knowledge base on interventions that will improve the
effectiveness and coverage of anti-malaria interventions.
This study is expected to generate important evidence
to inform the malaria control programs and the public
regarding the effectiveness and cost-effectiveness of the
two major vector control interventions. The costs of our
intervention is similar to that of the existing malaria
control program so that they can be easily accepted by
the MOH. We anticipate that the findings of this study
will be used for an effective planning and implementa-
tion of vector control interventions.
Trial status
At the time of the submission of this manuscript, ethical
approval has been obtained and the trial had completed
a pilot study, baseline data collection and randomization,
and is ongoing.
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